FDA Approval of LEQVIO(R) (inclisiran)

Novartis has announced that LEQVIO® (inclisiran) has been approved by the FDA for patients with atherosclerotic cardiovascular disease (ASCVD) who need to further lower their bad cholesterol, despite being on a maximally tolerated statin. If interested, the LEQVIO full prescribing information can be found here: https://www.novartis.us/sites/www.novartis.us/files/leqvio.pdf Novartis is committed to continuing their work with the…

Read More

Surgeon General releases a Call to Action on Hypertension

The office of the Surgeon General releases a call to action recommending that hypertension control become a national public health priority, optimizing patient care, and building a community to help control high blood pressure. Progress made in controlling hypertension “is slipping away from us”, said, U.S. Surgeon General Jerome M. Adams, MD, MPH. This leaves…

Read More